Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
9
result was found. Results that relate to
Type 2 diabetes mellitus
Effects of GLP-1RA therapy in patients with overweight, obese type 2 diabetes mellitus and coronary heart disease
Published on
Journal of Mathematical Medicine
2023,36(2):144-149.
653 times
190 times
Si-Yuan XIE
Zi-Qiang ZHU
Glucagon-like peptide-1 receptor agonist
Type 2 diabetes mellitus
Coronary heart disease
Overweight
Obesity
Insulin sensitivity
Details
Rapid health technology assessment of dulaglutide for the treatment of type 2 diabetes mellitus
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(8):931-940.
872 times
300 times
Yuan YAO
Fen-Li SU
Xu SUN
Shi-Yin FENG
Fen XIONG
Qing-Qun CAI
Dulaglutide
Type 2 diabetes mellitus
Rapid health technology assessment
Details
Study of the correlation between glycosylated hemoglobin level, insulin resistance index, complications and psychological control sources in type 2 diabetes patients
Published on
Journal of Mathematical Medicine
2023,36(6):434-439.
588 times
188 times
Wen-Fang LI
Jing XIN
Xin-Feng HOU
Ya-Fei SHEN
Fei DENG
Type 2 diabetes mellitus
Psychological control source
Glycosylated hemoglobin
Insulin resistance index
Complication
Details
Risk factors and prediction model of ketosis tendency in patients with newly diagnosed type 2 diabetes mellitus
Published on
Journal of Mathematical Medicine
2023,36(8):586-591.
711 times
200 times
Jia-Yao CAI
Xue-Jiang GU
Yu-Hui PENG
Type 2 diabetes mellitus
Newly diagnosed
Ketosis tendency
Risk factor
Prediction model
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1275-1284.
392 times
284 times
Ya-Ping NIU
San-Bao CHAI
Jing-Zi MA
Meng ZHANG
Zuo-Xiang LIU
Shan-Shan WU
Feng SUN
Basal insulin
Oral hypoglycemic agents
Type 2 diabetes mellitus
Poor treatment effect
Umbrella review
Details
Influences of dapagliflozin on blood pressure variability and left ventricular mass index in patients with type 2 diabetes mellitus and hypertension
Published on
China Pharmacist
2023,36(12):413-419.
317 times
672 times
Sa-Sa LI
Bei-Bei YE
Xin LIU
Xia-Ling ZHU
Dapagliflozin
Type 2 diabetes mellitus
Hypertension
Blood pressure variability
Left ventricular mass index
Details
Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(4):388-401.
257 times
491 times
YU Tian
LIU Shaohua
WEI Anhua
GUO Jieru
ZHANG Chengliang
LIU Dong
LIU Zhelong
Glucagon-like peptide-1 receptor agonist
Metformin
Type 2 diabetes mellitus
Cost-utility
Markov model
Pharmacoeconomics
Details
Effect of Tanganjianwan combined with abdominal massage on glucose and lipid metabolism and inflammatory factors in patients of metformin treatment with obesity and type 2 diabetes mellitus
Published on
China Pharmacist
2024,27(4):595-602.
183 times
175 times
HU Lijuan
WAN Jing
ZHU Hao
Tanganjianwan
Abdominal massage
Obesity and type 2 diabetes mellitus
Glucose and lipid metabolism
Inflammatory factors
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
New Online
164 times
88 times
YU Tian
LIU Shaohua
WEI Anhua
GUO Jieru
ZHANG Chengliang
LIU Dong3
LIU Zhelong
Glucagon-like peptide 1 receptor agonists
Type 2 diabetes mellitus
Obesity or overweight
Efficacy
Safety
Meta-analysis
Randomized controlled trial
Details